6-K
File 001-15170
EXDENSUR APPROVED IN JAPAN
- Filing date
- 06 Jan 2026
- Reporting date
- 06 Jan 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,785 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 176-200 of 1,000 matching filings.
Per page
25
Current page
8
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 05 Jan 2026
- Reporting date
- 05 Jan 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 05 Jan 2026
- Reporting date
- 05 Jan 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
NUCALA FOR ADULTS WITH COPD APPROVED IN CHINA
- Filing date
- 05 Jan 2026
- Reporting date
- 05 Jan 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK TO LOWER DRUG PRICES AND EXPAND ACCESS IN US
- Filing date
- 23 Dec 2025
- Reporting date
- 23 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 22 Dec 2025
- Reporting date
- 22 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 22 Dec 2025
- Reporting date
- 22 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 19 Dec 2025
- Reporting date
- 19 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 18 Dec 2025
- Reporting date
- 18 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
EXDENSUR (DEPEMOKIMAB ULLA) APPROVED BY US FDA
- Filing date
- 17 Dec 2025
- Reporting date
- 17 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 17 Dec 2025
- Reporting date
- 17 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
EXDENSUR (DEPEMOKIMAB) UK MHRA APPROVAL
- Filing date
- 16 Dec 2025
- Reporting date
- 16 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 16 Dec 2025
- Reporting date
- 16 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-37627
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
- Filing date
- 15 Dec 2025
- Reporting date
- 11 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 15 Dec 2025
- Reporting date
- 15 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DEPEMOKIMAB RECEIVES POSITIVE CHMP OPINION
- Filing date
- 12 Dec 2025
- Reporting date
- 12 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
NUCALA RECEIVES POSITIVE CHMP OPINION FOR COPD
- Filing date
- 12 Dec 2025
- Reporting date
- 12 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
POSITIVE CHMP OPINION ON AREXVY FOR ALL ADULTS 18+
- Filing date
- 12 Dec 2025
- Reporting date
- 12 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 12 Dec 2025
- Reporting date
- 12 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BLUJEPA APPROVED IN US FOR GONORRHOEA INDICATION
- Filing date
- 11 Dec 2025
- Reporting date
- 11 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 11 Dec 2025
- Reporting date
- 11 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BLOCK LISTING APPLICATION
- Filing date
- 11 Dec 2025
- Reporting date
- 11 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 11 Dec 2025
- Reporting date
- 11 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 10 Dec 2025
- Reporting date
- 10 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK'227 US FDA ORPHAN DRUG DESIGNATION IN SCLC
- Filing date
- 10 Dec 2025
- Reporting date
- 10 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing